ALZN's logo.
Ticker Symbol: ALZN

Alzamend Neuro Inc

$2.27 - 21-07-2024 4 p.m. ET

Exchange: NASDAQ Country: United States Currency: USD Asset Type: Common Stock CIK:0001677077

Company Profile

alzamend neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of alzheimer’s disease, bipolar disorder, major depressive disorder (“mdd”) and post-traumatic stress disorder (“ptsd”). our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ million americans suffering from these debilitating diseases. our current pipeline consists of two novel therapeutic drug candidates, al001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and alzn002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat alzheimer’s.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 3802 Spectrum Blvd,
Tags: N/A


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.20
Change: $0.00 ( -1.03%)
Days Range: $0.20 - $0.21
Beta: 1.08
52wk. High: $1.32
52wk. Low: $0.18
Ytd. Change -65.43%
50 Day Moving Average: $0.22
200 Day Moving Average: $0.44
Shares Outstanding: 96940124


Market Cap: 1.9B
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A